Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Sees Significant Growth in Short Interest

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) was the target of a significant increase in short interest in August. As of August 14th, there was short interest totaling 82,653 shares, an increase of 51.1% from the July 30th total of 54,710 shares. Based on an average daily trading volume, of 2,525,183 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are sold short.

Advanced Medical Isotope Stock Down 4.3%

Shares of OTCMKTS:RDGL opened at $0.05 on Tuesday. Advanced Medical Isotope has a fifty-two week low of $0.05 and a fifty-two week high of $0.12. The firm’s 50 day moving average price is $0.06 and its 200 day moving average price is $0.07. The stock has a market cap of $25.19 million, a price-to-earnings ratio of -5.10 and a beta of -0.73.

About Advanced Medical Isotope

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.